References
Abarrategi A, Mian SA, Passaro D, Rouault-Pierre K, Grey W, & Bonnet D (2018). Modeling the human bone marrow niche in mice: From host bone marrow engraftment to bioengineering approaches. The Journal of experimental medicine 215: 729-743.
Adams JM, Harris AW, Pinkert CA, Corcoran LM, Alexander WS, Cory S, et al. (1985). The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 318: 533-538.
Agarwal S, Hanauer JDS, Frank AM, Riechert V, Thalheimer FB, & Buchholz CJ (2020). In Vivo Generation of CAR T Cells Selectively in Human CD4(+) Lymphocytes. Molecular therapy : the journal of the American Society of Gene Therapy 28: 1783-1794.
Ahmadi Ghezeldasht S, Shirdel A, Assarehzadegan MA, Hassannia T, Rahimi H, Miri R, et al. (2013). Human T Lymphotropic Virus Type I (HTLV-I) Oncogenesis: Molecular Aspects of Virus and Host Interactions in Pathogenesis of Adult T cell Leukemia/Lymphoma (ATL). Iranian journal of basic medical sciences 16: 179-195.
Aida Y, Murakami H, Takahashi M, & Takeshima SN (2013). Mechanisms of pathogenesis induced by bovine leukemia virus as a model for human T-cell leukemia virus. Frontiers in microbiology 4: 328.
Altanerova V, Portetelle D, Kettmann R, & Altaner C (1989). Infection of rats with bovine leukaemia virus: establishment of a virus-producing rat cell line. The Journal of general virology 70 ( Pt 7):1929-1932.
Anderson MR, Pleet ML, Enose-Akahata Y, Erickson J, Monaco MC, Akpamagbo Y, et al. (2018). Viral antigens detectable in CSF exosomes from patients with retrovirus associated neurologic disease: functional role of exosomes. Clinical and translational medicine 7: 24.
Ballesteros-Arias L, Silva JG, Paiva RA, Carbonetto B, Faísca P, & Martins VC (2019). T Cell Acute Lymphoblastic Leukemia as a Consequence of Thymus Autonomy. Journal of immunology (Baltimore, Md : 1950) 202: 1137-1144.
Banerjee P, Tripp A, Lairmore MD, Crawford L, Sieburg M, Ramos JC, et al. (2010). Adult T-cell leukemia/lymphoma development in HTLV-1-infected humanized SCID mice. Blood 115: 2640-2648.
Bonnet D, & Dick JE (1997). Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nature medicine 3: 730-737.
Bosma GC, Custer RP, & Bosma MJ (1983). A severe combined immunodeficiency mutation in the mouse. Nature 301: 527-530.
Bua L, Tibaldi E, Falcioni L, Lauriola M, De Angelis L, Gnudi F, et al. (2018). Results of lifespan exposure to continuous and intermittent extremely low frequency electromagnetic fields (ELFEMF) administered alone to Sprague Dawley rats. Environmental research 164: 271-279.
Bulaeva E, Pellacani D, Nakamichi N, Hammond CA, Beer PA, Lorzadeh A, et al. (2020). MYC-induced human acute myeloid leukemia requires a continuing IL-3/GM-CSF costimulus. Blood 136:2764-2773.
Campbell KJ, Vandenberg CJ, Anstee NS, Hurlin PJ, & Cory S (2017). Mnt modulates Myc-driven lymphomagenesis. Cell death and differentiation 24: 2117-2126.
Carroll AM, Hardy RR, & Bosma MJ (1989). Occurrence of mature B (IgM+, B220+) and T (CD3+) lymphocytes in scid mice. Journal of immunology (Baltimore, Md : 1950) 143: 1087-1093.
Carter BZ, Mak PY, Mu H, Zhou H, Mak DH, Schober W, et al.(2016). Combined targeting of BCL-2 and BCR-ABL tyrosine kinase eradicates chronic myeloid leukemia stem cells. Science translational medicine 8: 355ra117.
Casazza AM, Pratesi G, Giuliani F, & Di Marco A (1980). Antileukemic activity of 4-demethoxydaunorubicin in mice. Tumori 66:549-564.
Cavallo F, Forni M, Riccardi C, Soleti A, Di Pierro F, & Forni G (1992). Growth and spread of human malignant T lymphoblasts in immunosuppressed nude mice: a model for meningeal leukemia. Blood 80: 1279-1283.
Chen W, Li Q, Hudson WA, Kumar A, Kirchhof N, & Kersey JH (2006). A murine Mll-AF4 knock-in model results in lymphoid and myeloid deregulation and hematologic malignancy. Blood 108: 669-677.
Chiang MY, Shestova O, Xu L, Aster JC, & Pear WS (2013). Divergent effects of supraphysiologic Notch signals on leukemia stem cells and hematopoietic stem cells. Blood 121: 905-917.
Choi B, Chun E, Kim M, Kim ST, Yoon K, Lee KY, et al. (2011). Human B cell development and antibody production in humanized NOD/SCID/IL-2Rγ(null) (NSG) mice conditioned by busulfan. Journal of clinical immunology 31: 253-264.
Committee on the Analysis of Cancer Risks in Populations near Nuclear Facilities-Phase I, Nuclear, Radiation Studies B, Division on E, Life S, & National Research C (2012). In Analysis of Cancer Risks in Populations Near Nuclear Facilities: Phase I. National Academies Press (US)
Copyright 2012 by the National Academy of Sciences. All rights reserved.: Washington (DC).
Corral J, Lavenir I, Impey H, Warren AJ, Forster A, Larson TA, et al. (1996). An Mll-AF9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: a method to create fusion oncogenes. Cell 85: 853-861.
Currer R, Van Duyne R, Jaworski E, Guendel I, Sampey G, Das R, et al. (2012). HTLV tax: a fascinating multifunctional co-regulator of viral and cellular pathways. Frontiers in microbiology 3: 406.
den Hoed MA, Pluijm SM, te Winkel ML, de Groot-Kruseman HA, Fiocco M, Hoogerbrugge P, et al. (2015). Aggravated bone density decline following symptomatic osteonecrosis in children with acute lymphoblastic leukemia. Haematologica 100: 1564-1570.
Drynan LF, Pannell R, Forster A, Chan NM, Cano F, Daser A, et al.(2005). Mll fusions generated by Cre-loxP-mediated de novo translocations can induce lineage reassignment in tumorigenesis. The EMBO journal 24: 3136-3146.
Erikson J, Finger L, Sun L, ar-Rushdi A, Nishikura K, Minowada J, et al. (1986). Deregulation of c-myc by translocation of the alpha-locus of the T-cell receptor in T-cell leukemias. Science (New York, NY) 232: 884-886.
Foà R, Bassan R, Vitale A, Elia L, Piciocchi A, Puzzolo MC, et al. (2020). Dasatinib-Blinatumomab for Ph-Positive Acute Lymphoblastic Leukemia in Adults. The New England journal of medicine 383:1613-1623.
Fogh J, Fogh JM, & Orfeo T (1977). One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. Journal of the National Cancer Institute 59: 221-226.
Forsberg EMV, Lindberg MF, Jespersen H, Alsén S, Bagge RO, Donia M, et al. (2019). HER2 CAR-T Cells Eradicate Uveal Melanoma and T-cell Therapy-Resistant Human Melanoma in IL2 Transgenic NOD/SCID IL2 Receptor Knockout Mice. Cancer research 79: 899-904.
Forster A, Pannell R, Drynan LF, McCormack M, Collins EC, Daser A, et al. (2003). Engineering de novo reciprocal chromosomal translocations associated with Mll to replicate primary events of human cancer. Cancer cell 3: 449-458.
Fortier JM, & Graubert TA (2010). Murine models of human acute myeloid leukemia. Cancer treatment and research 145: 183-196.
Friend C (1957). Cell-free transmission in adult Swiss mice of a disease having the character of a leukemia. The Journal of experimental medicine 105: 307-318.
Gál F, Somfai S, & Szentirmay Z (1973). Transplantable myeloid rat leukaemia induced by 7,12-dimethylbenz(a)anthracene. Acta haematologica 49: 281-290.
Gallo RC, Willems L, & Hasegawa H (2016). Screening transplant donors for HTLV-1 and -2. Blood 128: 3029-3031.
Gianfelici V, Chiaretti S, Demeyer S, Di Giacomo F, Messina M, La Starza R, et al. (2016). RNA sequencing unravels the genetics of refractory/relapsed T-cell acute lymphoblastic leukemia. Prognostic and therapeutic implications. Haematologica 101: 941-950.
Graves DC, & Ferrer JF (1976). In vitro transmission and propagation of the bovine leukemia virus in monolayer cell cultures. Cancer research 36: 4152-4159.
Gutierrez A, Grebliunaite R, Feng H, Kozakewich E, Zhu S, Guo F, et al. (2011). Pten mediates Myc oncogene dependence in a conditional zebrafish model of T cell acute lymphoblastic leukemia. The Journal of experimental medicine 208: 1595-1603.
Harris AW, Pinkert CA, Crawford M, Langdon WY, Brinster RL, & Adams JM (1988). The E mu-myc transgenic mouse. A model for high-incidence spontaneous lymphoma and leukemia of early B cells. The Journal of experimental medicine 167: 353-371.
Harrison NR, Laroche FJ, Gutierrez A, & Feng H (2016). Zebrafish Models of Human Leukemia: Technological Advances and Mechanistic Insights. Advances in experimental medicine and biology 916: 335-369.
Huggins CB, Grand L, & Ueda N (1982). Specific induction of erythroleukemia and myelogenous leukemia in Sprague-Dawley rats. Proceedings of the National Academy of Sciences of the United States of America 79: 5411-5414.
Huggins CB, & Sugiyama T (1966). Induction of leukemia in rat by pulse doses of 7,12-dimethylbenz(a)anthracene. Proceedings of the National Academy of Sciences of the United States of America 55: 74-81.
Idilli AI, Precazzini F, Mione MC, & Anelli V (2017). Zebrafish in Translational Cancer Research: Insight into Leukemia, Melanoma, Glioma and Endocrine Tumor Biology. Genes 8.
Ihle JN (1978). Experimental models and conceptual approaches to studies of lymphomas and leukemia: etiology, biology, and control. Seminars in hematology 15: 95-115.
Inaba H, & Mullighan CG (2020). Pediatric acute lymphoblastic leukemia. Haematologica 105: 2524-2539.
Ito M, Hiramatsu H, Kobayashi K, Suzue K, Kawahata M, Hioki K, et al. (2002). NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood 100: 3175-3182.
Jabbour E, O’Brien S, Konopleva M, & Kantarjian H (2015). New insights into the pathophysiology and therapy of adult acute lymphoblastic leukemia. Cancer 121: 2517-2528.
Jeha S, Kantarjian H, O’Brien S, Huh Y, Pisa P, Ordonez N, et al.(1995). Growth and biologic properties of karyotypically defined subcategories of adult acute lymphocytic leukemia in mice with severe combined immunodeficiency. Blood 86: 4278-4285.
Jensen PB, Roed H, Skovsgaard T, Friche E, Vindeløv L, Hansen HH, et al. (1990). Antitumor activity of the two epipodophyllotoxin derivatives VP-16 and VM-26 in preclinical systems: a comparison of in vitro and in vivo drug evaluation. Cancer chemotherapy and pharmacology 27: 194-198.
Kaplan HS (1952). Radiation-induced lymphoid tumors of mice. Acta - Unio Internationalis Contra Cancrum 7: 849-859.
Kaur P, Feldhahn N, Zhang B, Trageser D, Müschen M, Pertz V, et al. (2007). Nilotinib treatment in mouse models of P190 Bcr/Abl lymphoblastic leukemia. Molecular cancer 6: 67.
Kline I, Venditti JM, Tyrer DD, Mantel N, & Goldin A (1966). Chemotherapy of leukemia L1210 in mice with 1-beta-D-arabinofuranosylcytosine hydrochloride. II. Effectiveness against intracerebrally and subcutaneously inoculated leukemic cells. Cancer research 26: 1930-1937.
Knight SC, Macatonia SE, Cruickshank K, Rudge P, & Patterson S (1993). Dendritic cells in HIV-1 and HTLV-1 infection. Advances in experimental medicine and biology 329: 545-549.
Koller BH, & Smithies O (1989). Inactivating the beta 2-microglobulin locus in mouse embryonic stem cells by homologous recombination. Proceedings of the National Academy of Sciences of the United States of America 86: 8932-8935.
Langenau DM, Feng H, Berghmans S, Kanki JP, Kutok JL, & Look AT (2005). Cre/lox-regulated transgenic zebrafish model with conditional myc-induced T cell acute lymphoblastic leukemia. Proceedings of the National Academy of Sciences of the United States of America 102: 6068-6073.
Langenau DM, Traver D, Ferrando AA, Kutok JL, Aster JC, Kanki JP, et al. (2003). Myc-induced T cell leukemia in transgenic zebrafish. Science (New York, NY) 299: 887-890.
Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J, et al. (1994). A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367: 645-648.
Law LW, Taormina V, & Boyle PJ (1954). Response of acute lymphocytic leukemias to the purine antagonist 6-mercaptopurine. Annals of the New York Academy of Sciences 60: 244-250.
Lebestky T, Chang T, Hartenstein V, & Banerjee U (2000). Specification of Drosophila hematopoietic lineage by conserved transcription factors. Science (New York, NY) 288: 146-149.
Lee CL, Brock KD, Hasapis S, Zhang D, Sibley AB, Qin X, et al.(2021). Whole-Exome Sequencing of Radiation-Induced Thymic Lymphoma in Mouse Models Identifies Notch1 Activation as a Driver of p53 Wild-Type Lymphoma. Cancer research 81: 3777-3790.
Lieberman M, & Kaplan HS (1959). Leukemogenic activity of filtrates from radiation-induced lymphoid tumors of mice. Science (New York, NY) 130: 387-388.
Little MP, Weiss HA, Boice JD, Jr., Darby SC, Day NE, & Muirhead CR (1999). Risks of leukemia in Japanese atomic bomb survivors, in women treated for cervical cancer, and in patients treated for ankylosing spondylitis. Radiation research 152: 280-292.
Liu C, Li B, Cheng Y, Lin J, Hao J, Zhang S, et al. (2011). MiR-21 plays an important role in radiation induced carcinogenesis in BALB/c mice by directly targeting the tumor suppressor gene Big-h3. International journal of biological sciences 7: 347-363.
Luong-Gardiol N, Siddiqui I, Pizzitola I, Jeevan-Raj B, Charmoy M, Huang Y, et al. (2019). γ-Catenin-Dependent Signals Maintain BCR-ABL1(+) B Cell Acute Lymphoblastic Leukemia. Cancer cell 35: 649-663.e610.
Mammerickx M, Portetelle D, & Burny A (1981). Experimental cross-transmissions of bovine leukemia virus (BLV) between several animal species. Zentralblatt fur Veterinarmedizin Reihe B Journal of veterinary medicine Series B 28: 69-81.
Martin F, Tagaya Y, & Gallo R (2018). Time to eradicate HTLV-1: an open letter to WHO. Lancet (London, England) 391: 1893-1894.
McCormack E, Bruserud O, & Gjertsen BT (2005). Animal models of acute myelogenous leukaemia - development, application and future perspectives. Leukemia 19: 687-706.
Menzl I, Zhang T, Berger-Becvar A, Grausenburger R, Heller G, Prchal-Murphy M, et al. (2019). A kinase-independent role for CDK8 in BCR-ABL1(+) leukemia. Nature communications 10: 4741.
Metzler M, Forster A, Pannell R, Arends MJ, Daser A, Lobato MN, et al. (2006). A conditional model of MLL-AF4 B-cell tumourigenesis using invertor technology. Oncogene 25: 3093-3103.
Meyer LH, Eckhoff SM, Queudeville M, Kraus JM, Giordan M, Stursberg J, et al. (2011). Early relapse in ALL is identified by time to leukemia in NOD/SCID mice and is characterized by a gene signature involving survival pathways. Cancer cell 19: 206-217.
Milanovic M, Fan DNY, Belenki D, Däbritz JHM, Zhao Z, Yu Y, et al. (2018). Senescence-associated reprogramming promotes cancer stemness. Nature 553: 96-100.
Milne TA (2017). Mouse models of MLL leukemia: recapitulating the human disease. Blood 129: 2217-2223.
Mitchell P, Lee FT, Hall C, Rigopoulos A, Smyth FE, Hekman AM, et al. (2003). Targeting primary human Ph(+) B-cell precursor leukemia-engrafted SCID mice using radiolabeled anti-CD19 monoclonal antibodies. Journal of nuclear medicine : official publication, Society of Nuclear Medicine 44: 1105-1112.
Nagamoto Y, Takayama K, Tashiro K, Tateno C, Sakurai F, Tachibana M, et al. (2015). Efficient Engraftment of Human Induced Pluripotent Stem Cell-Derived Hepatocyte-Like Cells in uPA/SCID Mice by Overexpression of FNK, a Bcl-xL Mutant Gene. Cell transplantation 24: 1127-1138.
Nara N, & Miyamoto T (1982). Direct and serial transplantation of human acute myeloid leukaemia into nude mice. British journal of cancer 45: 778-782.
Nonoyama S, Smith FO, Bernstein ID, & Ochs HD (1993). Strain-dependent leakiness of mice with severe combined immune deficiency. Journal of immunology (Baltimore, Md : 1950) 150: 3817-3824.
O’Brien G, Cruz-Garcia L, Zyla J, Brown N, Finnon R, Polanska J, et al. (2020). Kras mutations and PU.1 promoter methylation are new pathways in murine radiation-induced AML. Carcinogenesis 41:1104-1112.
Otová B, Sladká M, Panczak A, & Marinov I (1997). Biological characteristics of spontaneous transplantable T-cell lymphomas in inbred Sprague-Dawley/cub rats. Transplantation proceedings 29:1754-1755.
Palomero T, Sulis ML, Cortina M, Real PJ, Barnes K, Ciofani M, et al. (2007). Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia. Nature medicine 13: 1203-1210.
Panoutsakopoulou V, Little CS, Sieck TG, Blankenhorn EP, & Blank KJ (1998). Differences in the immune response during the acute phase of E-55+ murine leukemia virus infection in progressor BALB and long term nonprogressor C57BL mice. Journal of immunology (Baltimore, Md : 1950) 161: 17-26.
Patel B, Dey A, Castleton AZ, Schwab C, Samuel E, Sivakumaran J, et al. (2014). Mouse xenograft modeling of human adult acute lymphoblastic leukemia provides mechanistic insights into adult LIC biology. Blood 124: 96-105.
Pfeiffer A, Thalheimer FB, Hartmann S, Frank AM, Bender RR, Danisch S, et al. (2018). In vivo generation of human CD19-CAR T cells results in B-cell depletion and signs of cytokine release syndrome. EMBO molecular medicine 10.
Pinto DO, DeMarino C, Pleet ML, Cowen M, Branscome H, Al Sharif S, et al. (2019). HTLV-1 Extracellular Vesicles Promote Cell-to-Cell Contact. Frontiers in microbiology 10: 2147.
Potter M (1985). History of the BALB/c family. Current topics in microbiology and immunology 122: 1-5.
Preston DL, Kusumi S, Tomonaga M, Izumi S, Ron E, Kuramoto A, et al. (1994). Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987. Radiation research 137: S68-97.
Priceputu E, Bouallaga I, Zhang Y, Li X, Chrobak P, Hanna ZS, et al. (2006). Structurally distinct ligand-binding or ligand-independent Notch1 mutants are leukemogenic but affect thymocyte development, apoptosis, and metastasis differently. Journal of immunology (Baltimore, Md : 1950) 177: 2153-2166.
Prochazka M, Gaskins HR, Shultz LD, & Leiter EH (1992). The nonobese diabetic scid mouse: model for spontaneous thymomagenesis associated with immunodeficiency. Proceedings of the National Academy of Sciences of the United States of America 89: 3290-3294.
Queudeville M, Seyfried F, Eckhoff SM, Trentin L, Ulrich S, Schirmer M, et al. (2012). Rapid engraftment of human ALL in NOD/SCID mice involves deficient apoptosis signaling. Cell death & disease 3: e364.
Quint W, Quax W, van der Putten H, & Berns A (1981). Characterization of AKR murine leukemia virus sequences in AKR mouse substrains and structure of integrated recombinant genomes in tumor tissues. Journal of virology 39: 1-10.
Rein A (2011). Murine leukemia viruses: objects and organisms. Advances in virology 2011: 403419.
Reinisch A, Etchart N, Thomas D, Hofmann NA, Fruehwirth M, Sinha S, et al. (2015). Epigenetic and in vivo comparison of diverse MSC sources reveals an endochondral signature for human hematopoietic niche formation. Blood 125: 249-260.
Reinisch A, Thomas D, Corces MR, Zhang X, Gratzinger D, Hong WJ, et al. (2016). A humanized bone marrow ossicle xenotransplantation model enables improved engraftment of healthy and leukemic human hematopoietic cells. Nature medicine 22: 812-821.
Richter-Pechańska P, Kunz JB, Hof J, Zimmermann M, Rausch T, Bandapalli OR, et al. (2017). Identification of a genetically defined ultra-high-risk group in relapsed pediatric T-lymphoblastic leukemia. Blood cancer journal 7: e523.
Rithidech K, Dunn JJ, Bond VP, Gordon CR, & Cronkite EP (1999). Characterization of genetic instability in radiation- and benzene-induced murine acute leukemia. Mutation research 428:33-39.
Rivina L, Davoren M, & Schiestl RH (2014). Radiation-induced myeloid leukemia in murine models. Human genomics 8: 13.
Sabaawy HE, Azuma M, Embree LJ, Tsai HJ, Starost MF, & Hickstein DD (2006). TEL-AML1 transgenic zebrafish model of precursor B cell acute lymphoblastic leukemia. Proceedings of the National Academy of Sciences of the United States of America 103: 15166-15171.
Sánchez-Martínez D, Baroni ML, Gutierrez-Agüera F, Roca-Ho H, Blanch-Lombarte O, González-García S, et al. (2019). Fratricide-resistant CD1a-specific CAR T cells for the treatment of cortical T-cell acute lymphoblastic leukemia. Blood 133:2291-2304.
Sawyers CL, Gishizky ML, Quan S, Golde DW, & Witte ON (1992). Propagation of human blastic myeloid leukemias in the SCID mouse. Blood 79: 2089-2098.
Seita J, Asakawa M, Ooehara J, Takayanagi S, Morita Y, Watanabe N, et al. (2008). Interleukin-27 directly induces differentiation in hematopoietic stem cells. Blood 111: 1903-1912.
Shultz LD, Schweitzer PA, Christianson SW, Gott B, Schweitzer IB, Tennent B, et al. (1995). Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. Journal of immunology (Baltimore, Md : 1950) 154: 180-191.
Skipper HE, & Perry S (1970). Kinetics of normal and leukemic leukocyte populations and relevance to chemotherapy. Cancer research 30:1883-1897.
Sodré Barmpas DB, Monteiro DLM, Taquette SR, Rodrigues NCP, Trajano AJB, Cunha JC, et al. (2019). Pregnancy outcomes and mother-to-child transmission rate in HTLV-1/2 infected women attending two public hospitals in the metropolitan area of Rio de Janeiro. PLoS neglected tropical diseases 13: e0007404.
Sontakke P, Carretta M, Jaques J, Brouwers-Vos AZ, Lubbers-Aalders L, Yuan H, et al. (2016). Modeling BCR-ABL and MLL-AF9 leukemia in a human bone marrow-like scaffold-based xenograft model. Leukemia 30: 2064-2073.
Steele JP, Clutterbuck RD, Powles RL, Mitchell PL, Horton C, Morilla R, et al. (1997). Growth of human T-cell lineage acute leukemia in severe combined immunodeficiency (SCID) mice and non-obese diabetic SCID mice. Blood 90: 2015-2019.
Svejda J, Kossey P, Hlavayova E, & Svec F (1958). Histological picture of the transplantable rat leukaemia induced by x-irradiation and methylcholanthrene. Neoplasma 5: 123-131.
Takabatake T, Kakinuma S, Hirouchi T, Nakamura MM, Fujikawa K, Nishimura M, et al. (2008). Analysis of changes in DNA copy number in radiation-induced thymic lymphomas of susceptible C57BL/6, resistant C3H and hybrid F1 Mice. Radiation research 169: 426-436.
Tamai H, Miyake K, Takatori M, Miyake N, Yamaguchi H, Dan K, et al. (2011). Activated K-Ras protein accelerates human MLL/AF4-induced leukemo-lymphomogenicity in a transgenic mouse model. Leukemia 25: 888-891.
Tamai H, Miyake K, Yamaguchi H, Takatori M, Dan K, Inokuchi K, et al. (2012). AAV8 vector expressing IL24 efficiently suppresses tumor growth mediated by specific mechanisms in MLL/AF4-positive ALL model mice. Blood 119: 64-71.
Tamai H, Yamaguchi H, Miyake K, Takatori M, Kitano T, Yamanaka S, et al. (2017). Amlexanox Downregulates S100A6 to Sensitize KMT2A/AFF1-Positive Acute Lymphoblastic Leukemia to TNFα Treatment. Cancer research 77: 4426-4433.
Tan SH, Bertulfo FC, & Sanda T (2017). Leukemia-Initiating Cells in T-Cell Acute Lymphoblastic Leukemia. Frontiers in oncology 7:218.
Teepen JC, van Leeuwen FE, Tissing WJ, van Dulmen-den Broeder E, van den Heuvel-Eibrink MM, van der Pal HJ, et al. (2017). Long-Term Risk of Subsequent Malignant Neoplasms After Treatment of Childhood Cancer in the DCOG LATER Study Cohort: Role of Chemotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 35: 2288-2298.
Terwilliger T, & Abdul-Hay M (2017). Acute lymphoblastic leukemia: a comprehensive review and 2017 update. Blood cancer journal 7:e577.
Thomas KR, & Capecchi MR (1987). Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell 51: 503-512.
Tsuji H, Ishii-Ohba H, Shiomi T, Shiomi N, Katsube T, Mori M, et al. (2013). Nature of nontargeted radiation effects observed during fractionated irradiation-induced thymic lymphomagenesis in mice. Journal of radiation research 54: 453-466.
Verhoeven Y, Tilborghs S, Jacobs J, De Waele J, Quatannens D, Deben C, et al. (2020). The potential and controversy of targeting STAT family members in cancer. Seminars in cancer biology 60: 41-56.
Voncken JW, Kaartinen V, Pattengale PK, Germeraad WT, Groffen J, & Heisterkamp N (1995). BCR/ABL P210 and P190 cause distinct leukemia in transgenic mice. Blood 86: 4603-4611.
Wang JX, Zhang L, Huang ZW, Zhang XN, Jiang YY, Liu FJ, et al.(2020). Aurora kinase inhibitor restrains STAT5-activated leukemic cell proliferation by inducing mitochondrial impairment. Journal of cellular physiology 235: 8358-8370.
Wang X, Yang J, Guo G, Feng R, Chen K, Liao Y, et al. (2019). Novel lncRNA-IUR suppresses Bcr-Abl-induced tumorigenesis through regulation of STAT5-CD71 pathway. Molecular cancer 18: 84.
Wei MC, & Cleary ML (2014). Novel methods and approaches to acute lymphoblastic leukemia drug discovery. Expert opinion on drug discovery 9: 1435-1446.
Weiser KC, Liu B, Hansen GM, Skapura D, Hentges KE, Yarlagadda S, et al. (2007). Retroviral insertions in the VISION database identify molecular pathways in mouse lymphoid leukemia and lymphoma. Mammalian genome : official journal of the International Mammalian Genome Society 18: 709-722.
Weiss HA, Darby SC, Fearn T, & Doll R (1995). Leukemia mortality after X-ray treatment for ankylosing spondylitis. Radiation research 142: 1-11.
Weng AP, Ferrando AA, Lee W, Morris JPt, Silverman LB, Sanchez-Irizarry C, et al. (2004). Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science (New York, NY) 306:269-271.
Würtele H, Little KC, & Chartrand P (2003). Illegitimate DNA integration in mammalian cells. Gene therapy 10: 1791-1799.
You MJ, Medeiros LJ, & Hsi ED (2015). T-lymphoblastic leukemia/lymphoma. Am J Clin Pathol 144: 411-422.
Yu R, Wang D, Ren X, Zeng L, & Liu Y (2014). The growth-inhibitory and apoptosis-inducing effect of deferoxamine combined with arsenic trioxide on HL-60 xenografts in nude mice. Leukemia research 38:1085-1090.
Yu W, Li L, Wang G, Zhang W, Xu J, & Liang A (2018). KU70 Inhibition Impairs Both Non-Homologous End Joining and Homologous Recombination DNA Damage Repair Through SHP-1 Induced Dephosphorylation of SIRT1 in T-Cell Acute Lymphoblastic Leukemia (T-ALL) [corrected]. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 49:2111-2123.
Yuan X, Dong Y, Tsurushita N, Tso JY, & Fu W (2018). CD122 blockade restores immunological tolerance in autoimmune type 1 diabetes via multiple mechanisms. JCI insight 3.
Yun JP, Behan JW, Heisterkamp N, Butturini A, Klemm L, Ji L, et al. (2010). Diet-induced obesity accelerates acute lymphoblastic leukemia progression in two murine models. Cancer prevention research (Philadelphia, Pa) 3: 1259-1264.
Zhang Y, Hua C, Cheng H, Wang W, Hao S, Xu J, et al. (2013). Distinct sensitivity of CD8+ CD4- and CD8+ CD4+ leukemic cell subpopulations to cyclophosphamide and rapamycin in Notch1-induced T-ALL mouse model. Leukemia research 37: 1592-1601.
Zorzoli A, Di Carlo E, Cocco C, Ognio E, Ribatti D, Ferretti E, et al. (2012). Interleukin-27 inhibits the growth of pediatric acute myeloid leukemia in NOD/SCID/Il2rg-/- mice. Clinical cancer research : an official journal of the American Association for Cancer Research 18: 1630-1640.